Trunet PF - Search Results

1

Letrozole, a new oral non-steroidal aromastase inhibitor in treating postmenopausal patients with advanced breast cancer. A pilot study.

Bisagni G, Cocconi G, Scaglione F, Fraschini F, Pfister C, Trunet PF. Bisagni G, et al. Among authors: trunet pf. Ann Oncol. 1996 Jan;7(1):99-102. doi: 10.1093/oxfordjournals.annonc.a010490. Ann Oncol. 1996. PMID: 9081401 Free article. Clinical Trial.

2

Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration.

Sioufi A, Sandrenan N, Godbillon J, Trunet P, Czendlik C, Howald H, Pfister C, Ezzet F. Sioufi A, et al. Biopharm Drug Dispos. 1997 Aug;18(6):489-97. doi: 10.1002/(sici)1099-081x(199708)18:6<489::aid-bdd36>3.0.co;2-p. Biopharm Drug Dispos. 1997. PMID: 9267682 Clinical Trial.

3

CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer--a phase I study.

Beretta KR, Hoeffken K, Kvinnsland S, Trunet P, Chaudri HA, Bhatnagar AS, Goldhirsch A, Cavalli F. Beretta KR, et al. Ann Oncol. 1990 Nov;1(6):421-6. doi: 10.1093/oxfordjournals.annonc.a057795. Ann Oncol. 1990. PMID: 2150591 Free article. Clinical Trial.

4

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffmann W, Michel J, Hatschek T, Tjabbes T, Chaudri HA, Hornberger U, Trunet PF. Dombernowsky P, et al. Among authors: trunet pf. J Clin Oncol. 1998 Feb;16(2):453-61. doi: 10.1200/JCO.1998.16.2.453. J Clin Oncol. 1998. PMID: 9469328 Clinical Trial.

5

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.

Iveson TJ, Smith IE, Ahern J, Smithers DA, Trunet PF, Dowsett M. Iveson TJ, et al. Among authors: trunet pf. Cancer Res. 1993 Jan 15;53(2):266-70. Cancer Res. 1993. PMID: 8417819 Clinical Trial.

6

Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients.

Trunet PF, Bhatnagar AS, Chaudri HA, Hornberger U. Trunet PF, et al. Acta Oncol. 1996;35 Suppl 5:15-8. doi: 10.3109/02841869609083962. Acta Oncol. 1996. PMID: 9142959 Review.

7

In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer.

Dowsett M, Jones A, Johnston SR, Jacobs S, Trunet P, Smith IE. Dowsett M, et al. Clin Cancer Res. 1995 Dec;1(12):1511-5. Clin Cancer Res. 1995. PMID: 9815951 Clinical Trial.

8

Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.

Lipton A, Demers LM, Harvey HA, Kambic KB, Grossberg H, Brady C, Adlercruetz H, Trunet PF, Santen RJ. Lipton A, et al. Among authors: trunet pf. Cancer. 1995 Apr 15;75(8):2132-8. doi: 10.1002/1097-0142(19950415)75:8<2132::aid-cncr2820750816>3.0.co;2-u. Cancer. 1995. PMID: 7697604 Clinical Trial.

9

Letrozole: which dose to be used?

Buzdar AU, Chaudri HA, Trunet PF. Buzdar AU, et al. Among authors: trunet pf. J Clin Oncol. 2000 Apr;18(8):1802-3. doi: 10.1200/JCO.2000.18.8.1802. J Clin Oncol. 2000. PMID: 10764444 No abstract available.

10

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.

Iveson TJ, Smith IE, Ahern J, Smithers DA, Trunet PF, Dowsett M. Iveson TJ, et al. Among authors: trunet pf. J Clin Endocrinol Metab. 1993 Aug;77(2):324-31. doi: 10.1210/jcem.77.2.8345035. J Clin Endocrinol Metab. 1993. PMID: 8345035 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters